Thermo Fisher Hears B.R.A.H.M.S.


Waltham, MA-based Thermo Fisher Scientific (NYSE: TMO), one of the world’s leading makers of diagnostic devices and lab equipment, said today that it has purchased Hennigsdorf, Germany-based B.R.A.H.M.S. for €330 million (US $470 million). B.R.A.H.M.S. is known for making a line of in vitro diagnostic tests based on patented biomarkers, including a test for sepsis widely used in Europe. A Thermo Fisher spokesperson said the acquisition would complement the company’s existing line of immunoassay testing products and give it “a significant reagent manufacturing footprint in Europe.”

Wade Roush is Chief Correspondent and Editor At Large at Xconomy. You can subscribe to his Google Group or e-mail him at Follow @

By posting a comment, you agree to our terms and conditions.